CompactaSteril – Reducing surgical site infections


Lars Wesén, founder of Compacta Ltd. (on the right) demonstrated the CompactaSteril prototype designed to reduce surgical site infection to Hannu Syrjälä, Chief of Department of Infection Control, Oulu University Hospital and Timo Alalääkkölä, Project Manager, OYS TestLab.

The CompactaSteril -prototype tests launched the practical testbed activities of Nordic Test Beds project. Lars Wesén, founder of Compacta company packed the prototype on to his car and drove all the way from Lund, southern Sweden to Oulu, northern Finland to present the CompactaSteril solution to doctors and nurses in OYS TestLab.

“We had 4 doctors and 3 nurses evaluating the prototype in OYS TestLab. Based on their comments and questions we will create a usability report about the product”, says Timo Alalääkkölä, Project Manager of OYS TestLab.

CompactaSteril is aimed to be used for surgeries and other infection sensitive procedures to reduce surgical site infections, i.e. infections that occurs after surgery in the part of the body where the surgery took place. Surgical site infections are the second most common type of hospital acquired infections and affect up to small but remarkable part of all patients undergoing a surgical procedure. With an increasing prevalence of multidrug-resistant bacteria in the healthcare settings, surgical site infection is becoming an even greater clinical concern.

“A primary cause of surgical site infections is airborne particles carrying bacteria”, says Wesén. “The CompactaSteril is a lightweight, mobile, ultra clean air zone creating solution based on the use of a combination of HEPA-filter and sealed UV light. The ultra clean air zone maintains sterility of the surgical site and the wound. The produced laminar airflow of ultra clean air hinders any surrounding microbial-containing particles from entering the sterile area.”

Compacta is a new company, and their innovation is new for the market. “It was very important for the company that we got this opportunity. CompactaSteril is not yet a medically approved device. But based on the ongoing prototype evaluation in the Nordics we will develop and optimize it further, and hope to get it CE-marked during 2016-2017”, says Wesén.

CompactaSteril is optimized for minor surgical procedures. It allows for treatment irrespective of the environment it is placed, and can be used e.g. in general practitioners’ office, emergency rooms, as well as in catastrophe areas.

After couple of days testing in Oulu, Wesén moved on with the prototype to Uppsala where he presented CompactaSteril to healthcare professionals in Innovation Akademiska test bed environment at Uppsala University Hospital.